Integrase inhibitors in children and adolescents: clinical use and resistance.

David Torres-FernandezSantiago Jiménez de OryClaudia FortunyTalía SainzDolores FalcónEnrique BernalMiguel Cervero JiménezMarta Navarro VilasaróCristina EpalzaMarisa NavarroJosé Tomás RamosÁfrica HolguínLuis Prietonull null

Published in: The Journal of antimicrobial chemotherapy (2022)

INI-based regimens were effective and safe for HIV treatment in children and adolescents. Dolutegravir and elvitegravir presented an excellent profile, and most patients achieved and maintained viral suppression.

Keyphrases

end stage renal disease
antiretroviral therapy
ejection fraction
newly diagnosed
chronic kidney disease
sars cov
human immunodeficiency virus
peritoneal dialysis
hepatitis c virus
smoking cessation